Search Results - "Sulkowski, Mark"

Viral hepatitis and HIV coinfection by Sulkowski, Mark S

“…Persons at high risk for human immunodeficiency virus (HIV) infection are also likely to be at risk for other infectious pathogens, including hepatitis B virus…”
Get full text

Hepatitis D virus infection: Progress on the path toward disease control and cure by Sulkowski, Mark S.

“…This article discusses the impact of Hepatitis D virus (HDV) infection as a major cause of liver‐related morbidity and mortality in people with Hepatitis B…”
Get full text

Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review by Falade-Nwulia, Oluwaseun, Suarez-Cuervo, Catalina, Nelson, David R, Fried, Michael W, Segal, Jodi B, Sulkowski, Mark S

“…Rapid improvements in hepatitis C virus (HCV) therapy have led to the approval of multiple oral direct-acting antiviral (DAA) regimens by the U.S. Food and…”
Get full text

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection by Sterling, Richard K., Lissen, Eduardo, Clumeck, Nathan, Sola, Ricard, Correa, Mendes Cassia, Montaner, Julio, S. Sulkowski, Mark, Torriani, Francesca J., Dieterich, Doug T., Thomas, David L., Messinger, Diethelm, Nelson, Mark

“…Liver biopsy remains the gold standard in the assessment of severity of liver disease. Noninvasive tests have gained popularity to predict histology in view of…”
Get full text

Hepatitis C Virus Treatment: Simplifying the Simple and Optimizing the Difficult by Falade-Nwulia, Oluwaseun, Sulkowski, Mark S

“…Abstract The availability of safe, efficacious, oral direct-acting antivirals (DAAs) have ushered in a new era of hepatitis C treatment with potential to…”
Get full text

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease by Charlton, Michael, Everson, Gregory T, Flamm, Steven L, Kumar, Princy, Landis, Charles, Brown, Robert S, Fried, Michael W, Terrault, Norah A, O'Leary, Jacqueline G, Vargas, Hugo E, Kuo, Alexander, Schiff, Eugene, Sulkowski, Mark S, Gilroy, Richard, Watt, Kymberly D, Brown, Kimberly, Kwo, Paul, Pungpapong, Surakit, Korenblat, Kevin M, Muir, Andrew J, Teperman, Lewis, Fontana, Robert J, Denning, Jill, Arterburn, Sarah, Dvory-Sobol, Hadas, Brandt-Sarif, Theo, Pang, Phillip S, McHutchison, John G, Reddy, K. Rajender, Afdhal, Nezam

“…Background & Aims There are no effective and safe treatments for chronic hepatitis C virus (HCV) infection of patients who have advanced liver disease. Methods…”
Get full text

Extrahepatic Morbidity and Mortality of Chronic Hepatitis C by Negro, Francesco, Forton, Daniel, Craxì, Antonio, Sulkowski, Mark S, Feld, Jordan J, Manns, Michael P

“…Chronic hepatitis C virus (HCV) infection is associated with several extrahepatic manifestations. Patients with HCV may develop mixed cryoglobulinemia and its…”
Get full text

The Proof Is in the Patient: Hepatitis C Virus Microelimination in the Swiss Human Immunodeficiency Virus Cohort Study by Sulkowski, Mark S

Get full text

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study by Lawitz, Eric, Prof, Sulkowski, Mark S, Prof, Ghalib, Reem, MD, Rodriguez-Torres, Maribel, MD, Younossi, Zobair M, Prof, Corregidor, Ana, MD, DeJesus, Edwin, MD, Pearlman, Brian, Prof, Rabinovitz, Mordechai, Prof, Gitlin, Norman, MD, Lim, Joseph K, MD, Pockros, Paul J, MD, Scott, John D, MD, Fevery, Bart, MSc, Lambrecht, Tom, MSc, Ouwerkerk-Mahadevan, Sivi, PhD, Callewaert, Katleen, MSc, Symonds, William T, PharmD, Picchio, Gaston, PhD, Lindsay, Karen L, MD, Beumont, Maria, MD, Jacobson, Ira M, Prof

“…Summary Background Interferon-free regimens are needed to treat hepatitis C virus (HCV) infections. We investigated the efficacy of combined simeprevir and…”
Get full text

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection by Sulkowski, Mark S, Gardiner, David F, Rodriguez-Torres, Maribel, Reddy, K. Rajender, Hassanein, Tarek, Jacobson, Ira, Lawitz, Eric, Lok, Anna S, Hinestrosa, Federico, Thuluvath, Paul J, Schwartz, Howard, Nelson, David R, Everson, Gregory T, Eley, Timothy, Wind-Rotolo, Megan, Huang, Shu-Pang, Gao, Min, Hernandez, Dennis, McPhee, Fiona, Sherman, Diane, Hindes, Robert, Symonds, William, Pasquinelli, Claudio, Grasela, Dennis M

“…In this study, once-daily treatment with oral daclatasvir plus sofosbuvir was associated with high rates of sustained virologic response among patients with…”
Get full text

HCV-HIV co-infected patients: no longer a 'special' population? by Sulkowski, Mark S.

“…Prior to the advent of safe and highly effective hepatitis C virus (HCV) treatment, patients with human immunodeficiency virus (HIV)/HCV co‐infection were…”
Get full text

Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals by Naggie, Susanna, Sulkowski, Mark S

“…With the development of effective therapies against human immunodeficiency virus (HIV), hepatitis C virus (HCV) infection has become a major cause of morbidity…”
Get full text

Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options by Jacobson, Ira M, Gordon, Stuart C, Kowdley, Kris V, Yoshida, Eric M, Rodriguez-Torres, Maribel, Sulkowski, Mark S, Shiffman, Mitchell L, Lawitz, Eric, Everson, Gregory, Bennett, Michael, Schiff, Eugene, Al-Assi, M. Tarek, Subramanian, G. Mani, An, Di, Lin, Ming, McNally, John, Brainard, Diana, Symonds, William T, McHutchison, John G, Patel, Keyur, Feld, Jordan, Pianko, Stephen, Nelson, David R

“…In two randomized trials, the oral nucleotide polymerase inhibitor sofosbuvir combined with ribavirin for 12 or 16 weeks was effective in patients with chronic…”
Get full text

Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment by Grudda, Tanner, Hwang, Hyon S, Taddese, Maraake, Quinn, Jeffrey, Sulkowski, Mark S, Sterling, Richard K, Balagopal, Ashwin, Thio, Chloe L

“…The focus of hepatitis B functional cure, defined as sustained loss of hepatitis B virus (HBV) surface antigen (HBsAg) and HBV DNA from blood, is on…”
Get full text

Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy by Wyles, David L., Sulkowski, Mark S., Dieterich, Douglas

“…The increased life expectancy of persons infected with human immunodeficiency virus (HIV) treated with antiretroviral therapy (ART) has resulted in renewed…”
Get full text

Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon‐ineligible/intolerant individuals by Hagan, Liesl M., Sulkowski, Mark S., Schinazi, Raymond F.

“…Treatment guidance for chronic hepatitis C (CHC) released by the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases…”
Get full text

Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease by Pockros, Paul J, Reddy, K. Rajender, Mantry, Parvez S, Cohen, Eric, Bennett, Michael, Sulkowski, Mark S, Bernstein, David E, Cohen, Daniel E, Shulman, Nancy S, Wang, Deli, Khatri, Amit, Abunimeh, Manal, Podsadecki, Thomas, Lawitz, Eric

“…Background & Aims Although hepatitis C virus (HCV) infection is common in patients with end-stage renal disease, highly efficacious, well-tolerated,…”
Get full text

Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment by Poordad, Fred, Felizarta, Franco, Asatryan, Armen, Sulkowski, Mark S., Reindollar, Robert W., Landis, Charles S., Gordon, Stuart C., Flamm, Steven L., Fried, Michael W., Bernstein, David E., Lin, Chih‐Wei, Liu, Ran, Lovell, Sandra S., Ng, Teresa I., Kort, Jens, Mensa, Federico J.

“…Although direct‐acting antiviral (DAA) therapies for chronic hepatitis C virus (HCV) infection have demonstrated high rates of sustained virologic response,…”
Get full text

Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1 by Kowdley, Kris V, Lawitz, Eric, Poordad, Fred, Cohen, Daniel E, Nelson, David R, Zeuzem, Stefan, Everson, Gregory T, Kwo, Paul, Foster, Graham R, Sulkowski, Mark S, Xie, Wangang, Pilot-Matias, Tami, Liossis, George, Larsen, Lois, Khatri, Amit, Podsadecki, Thomas, Bernstein, Barry

“…In this phase 2 study, peginterferon-free regimens were effective in patients with hepatitis C virus genotype 1 infection. Chronic hepatitis C virus (HCV)…”
Get full text

Management of Hepatic Complications in HIV-Infected Persons by Sulkowski, Mark S.

“…In the era of effective antiretroviral therapy (ART), liver disease is the second most common cause of death among persons with human immunodeficiency virus…”
Get full text